2-Amino-1-(3-bromo-phenyl)-ethanone; hydrochloride, 95.0%, 5g

(2-Isopropoxypyrimidin-5-yl)boronic acid, 95.0%, 5g

L-Cystine dihydrochloride, 98.0%, 500g

n-(2-Aminoethyl)-2,2-dimethylpropanamide hydrochloride, 95%, 2g

METHYL 2-BROMO-[1,2,4]TRIAZOLO[1,5-A]PYRIDINE-7-CARBOXYLATE, 95.0%, 1g

Heptane (isomers), min. 98.5%, for synthesis, 10 l, whitbl.

Sodium perrhenate 98% 10 g

Diethyl 2-(benzyloxy)malonate, 97%, 1g

(R)-2-Amino-2-(4-(trifluoromethyl)phenyl)ethanol, 95%, 1g

6-Fluoroimidazo[1,2-b]pyridazine, 97%, 5g

(2R)-2-[(tert-butoxycarbonyl)amino]-3-(6-chloropyridin-3-yl)propanoic acid, 250mg

5-Methoxy-2-nitrobenzoic Acid>97.0%(GC)(T)5g

1-((2R,3R,4R)-4-((tert-butyldimethylsilyl)oxy)-3-fluoro-5,5-bis(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 98%, 250mg